Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Vertex Pharmaceuticals
(NQ:
VRTX
)
401.08
+0.92 (+0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
May 03, 2024
Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.
Via
Investor's Business Daily
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
May 03, 2024
The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.
Via
InvestorPlace
3 Growth Stocks You’ll Kick Yourself for Not Buying Today
May 03, 2024
Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.
Via
InvestorPlace
Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar
May 03, 2024
Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.
Via
InvestorPlace
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest
April 25, 2024
Via
Benzinga
2 Fantastic Growth Stocks to Buy Right Now
April 25, 2024
Don't overlook these high-growth businesses.
Via
The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $6,000 Today
April 16, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
May 02, 2024
Via
Benzinga
2 Top Growth Stocks to Buy Right Now and Hold Forever
April 28, 2024
These healthcare stocks can provide enviable long-term portfolio growth.
Via
The Motley Fool
Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades.
April 27, 2024
These three should have a lot of room to run.
Via
The Motley Fool
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
April 26, 2024
Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.
Via
Benzinga
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Good news could be just around the corner for two drugmakers not named Novo Nordisk.
Via
The Motley Fool
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
April 23, 2024
Vertex is broadening its portfolio.
Via
The Motley Fool
The Analyst Landscape: 16 Takes On Vertex Pharmaceuticals
April 12, 2024
Via
Benzinga
Making Sense of Amazon CEO Andy Jassy's Latest Letter
April 22, 2024
And that's just part of the interesting news for investors to dig into.
Via
The Motley Fool
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
April 22, 2024
Could Vertex's growth story continue?
Via
The Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
April 22, 2024
These stocks could be near major inflection points.
Via
The Motley Fool
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
April 20, 2024
These stocks probably won't be getting much cheaper.
Via
The Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
Low risk and high-reward potential? These stocks could offer both.
Via
The Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.
Via
InvestorPlace
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
April 19, 2024
Does this pharma stock have the potential to turn a $25,000 investment into seven figures or more?
Via
The Motley Fool
Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday
April 18, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
April 18, 2024
The biotech just added another potential growth driver to its pipeline.
Via
The Motley Fool
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
April 15, 2024
Vertex just laid claim to an asset that might be very valuable.
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
April 13, 2024
Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.
Via
The Motley Fool
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review
April 12, 2024
The stock market gave some bullish signs, with Nvidia rebounding, but the indexes generally fell for the week on inflation and Mideast fears.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
April 11, 2024
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth...
Via
Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
April 11, 2024
Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
Via
InvestorPlace
Raymond James Just Raised Its Price Target on Nvidia (NVDA) Stock
April 11, 2024
Nvidia stock is on the move Thursday after shares of NVDA got an increased price target of $1,100 from Raymond James analysts.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
41
42
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.